Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0000950170-24-019044

Chief Legal Officer sold 7,606 shares at $0.68 ($5,172)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Wilson Mark Andrew Chief Legal Officer 2024-02-20 Sale −7,606 $0.68 $5,172 236,674 D: show line 1 in the form
Open-market sales · 7,606 sh · avg $0.68 · $5,172
Loading xslF345X05/ownership.xml…